all

The following is a National Lipid Association (NLA) Expert Clinical Consensus on the role of apolipoprotein (apo)B in adult patient care. This document is meant to clarify the role of apoB testing for clinicians who manage cardiovascular risk and lipid disorders, as well as health systems, payers, and medical associations. The 2021 NLA Scientific Statement, Lipid Measurements in the Management of section.

National Lipid Association Unveils New Mission to Advance Lipidology and Cardiometabolic Health

JACKSONVILLE, Fla. – (May 31, 2024) - The National Lipid Association (NLA) is proud to announce its renewed mission: “To enhance the science and practice of lipidology and promote optimal cardiometabolic health.” This updated mission underscores the NLA’s commitment to advancing the field of lipidology and improving health outcomes for individuals with lipid disorders.